Furthermore, SNAT5 and ASCT2 inhibition in primary B-ALL cells resulted in greater cell death than ASNase treatment, despite no observed cytotoxicity to BM-MSCs at the same concentration [101]. Here, SLC38A5 is linked to precursor B-cell acute lymphoblastic leukemia.